Christopher Nasveschuk

Christopher Nasveschuk is the Senior Vice President of Chemistry at C4 Therapeutics, Inc. Christopher oversees the Chemical Sciences group, focusing on the development of BiDACs to degrade disease-specific proteins. Previously, Christopher held roles at Broad Institute and Constellation Pharmaceuticals, where Christopher co-invented compounds for cancer treatment and led teams in medicinal chemistry. Nasveschuk holds a Ph.D. in Organic Chemistry from Colorado State University and has a background in Chemistry and Economics from Middlebury College.